Per Lidman
Partner, Member of the Swedish Bar Association
Profile
For over 20 years, I have worked primarily with issues linked to intellectual property law and commercial transactions, and with technology-intensive companies and their legal issues in general.
I have national responsibility for and lead Setterwalls’ Life Sciences team, and am in the same way responsible for trademark and marketing law issues. I am experienced at handling i.a. patent- and trademark litigation where issues are dealt with in several jurisdictions in parallel. Sectors where I have particularly relevant experience include pharmaceuticals and medtech, foods and high-technology companies in general. My experience as general counsel at a Swedish listed company in the biometrics sector and as previous Managing Partner at Setterwalls has given me valuable insights into the needs of clients, from the client’s viewpoint. Commercial contracts, including those in an international environment, constitute an exciting and stimulating part of my everyday work. I regard understanding the client’s business and goals as necessary for being able to deliver to the point and pragmatic advice. All in.
Språk: English, Swedish, Swedish
Karriär
2006-
Setterwalls
2005
Precise Biometrics, general counsel
2000-2005
Setterwalls
1999
Advokatfirman Lindahl
1999
Lund University, LL.M.
1999
University of California, Santa Barbara (UCSB), research studies
1993
Swedish Naval Academy
Rekommendationer
Case
Setterwalls has successfully represented a pharmaceutical company in a patent dispute before the Patent and Market Court of Appeal
Setterwalls has advised Asgard Therapeutics AB in connection with a EUR 30 million Series A financing
Setterwalls has successfully represented a pharmaceutical company in a patent dispute before the Patent and Market Court
Setterwalls has advised Respiratorius and Arcede Pharma in connection with a rights issue and Lex Asea distribution of shares
Setterwalls has advised inriver AB in connection with a major growth investment from Thomas H. Lee Partners (THL)
Setterwalls has advised Amniotics AB (publ) in connection with listing on Nasdaq First North Growth Market
Setterwalls assists Aurena Laboratories in deal value of 70 million euro
Setterwalls has assisted the Fristads Kansas Group in the sale of Fristads, Kansas and Leijona to Hultafors Group AB
Setterwalls advises inRiver in connection with private placement of approximately SEK 285 million
Setterwalls has assisted Ascelia Pharma in this year’s first listing at Nasdaq Stockholm
Setterwalls has advised EQL Pharma in connection with oversubscribed rights issue
Setterwalls advisor to Fox Networks Group in an agreement on the launch of National Geographic+ as part of Telia’s offering
Setterwalls assists BONESUPPORT in connection with listing on Nasdaq Stockholm
Setterwalls has assisted Cloetta in connection with the development and launch of the app Let’s Talk
Setterwalls assists when Skandia Fastigheter acquires a property located in the city centre of Malmö
Setterwalls assists LIDDS in connection with fundraising and listing on NASDAQ OMX First North
Setterwalls advised Diligentia in the sale of development rights to Hökerum Bygg.
Setterwalls assists in connection with a MSEK 120 investment round in Bonesupport
Artiklar
Has it become harder to obtain patent and specifically supplementary protection for pharmaceutical combination products?
Läs nyhet
The Swedish Food Agency is reducing the regulatory burden for food businesses
Läs nyhet
The Swedish Medical Products Agency is stepping up its market surveillance of e-commerce in medical devices
Läs nyhet
EU Court clarifies front‑of‑pack nutrition labelling for foods for special medical purposes: per‑portion figures included in such labelling constitute a prohibited repetition
Läs nyhet
When legal and important areas of interest collide – the impact of patent law on interchangeability
Läs nyhet
The Swedish Supreme Administrative Court seeks guidance from the CJEU on the interpretation of the provisions of EU law on the labelling of food for special medical purposes
Läs nyhet
UP/UPC Update: The UPC Agreement may enter into force already in the autumn of 2022
Läs nyhet
ICLG: Patent Law and Regulations 2022. Setterwalls’ experts explain Swedish patent law in the latest edition.
Läs nyhet
Nutrition and health claims in trademarks and product names – the transitional rule expires
Läs nyhet
Is your product or service sustainable and can you truly say that you are carbon neutral?
Läs nyhet
Setterwalls' experts explain patent litigation law in Sweden in this years’ edition of ICLG: Patents 2021
Läs nyhet
How to use your IP in times of crisis – 8 ideas to turn hardship into opportunity
Läs nyhet
UP/UPC Update: Premises of the Paris seat of the Court of First Instance are displayed
Läs nyhet
Setterwalls' experts explain the basics of litigating and commercializing patents in Sweden
Läs nyhet
Using alternative intellectual property rights to maintain and defend market share beyond patent protection for pharmaceuticals
Läs nyhet
How do you behave from a legal perspective in an open innovation environment?
Läs nyhet

